Abbott Laboratories (ABT) To Go Ex-Dividend on January 15th

Abbott Laboratories (NYSE:ABT) declared a quarterly dividend on Friday, December 12th. Shareholders of record on Thursday, January 15th will be paid a dividend of 0.63 per share by the healthcare product maker on Friday, February 13th. This represents a c) dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Thursday, January 15th. This is a 6.8% increase from Abbott Laboratories’s previous quarterly dividend of $0.59.

Abbott Laboratories has increased its dividend by an average of 0.1%per year over the last three years and has raised its dividend every year for the last 54 years. Abbott Laboratories has a dividend payout ratio of 44.4% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Abbott Laboratories to earn $5.73 per share next year, which means the company should continue to be able to cover its $2.52 annual dividend with an expected future payout ratio of 44.0%.

Abbott Laboratories Price Performance

ABT stock traded down $1.49 during trading on Tuesday, hitting $123.15. 448,686 shares of the stock traded hands, compared to its average volume of 5,132,968. The stock has a market cap of $214.15 billion, a price-to-earnings ratio of 15.44, a P/E/G ratio of 2.09 and a beta of 0.72. Abbott Laboratories has a one year low of $110.86 and a one year high of $141.23. The company has a 50 day simple moving average of $126.15 and a 200 day simple moving average of $129.24. The company has a current ratio of 1.70, a quick ratio of 1.24 and a debt-to-equity ratio of 0.23.

Abbott Laboratories (NYSE:ABT) last issued its earnings results on Wednesday, October 15th. The healthcare product maker reported $1.30 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.30. Abbott Laboratories had a return on equity of 17.60% and a net margin of 31.88%.The firm had revenue of $11.37 billion for the quarter, compared to analysts’ expectations of $11.40 billion. During the same quarter last year, the business earned $1.21 earnings per share. The company’s revenue was up 6.9% compared to the same quarter last year. Abbott Laboratories has set its FY 2025 guidance at 5.120-5.180 EPS. Equities analysts expect that Abbott Laboratories will post 5.14 EPS for the current fiscal year.

Abbott Laboratories Company Profile

Abbott Laboratories is a global healthcare company headquartered in Abbott Park, Illinois, that develops, manufactures and markets a broad portfolio of medical products and services. Founded in 1888, Abbott operates through multiple business areas that focus on diagnostics, medical devices, nutritionals and established pharmaceuticals. The company supplies hospitals, clinics, laboratories, retailers and direct-to-consumer channels with products intended to diagnose, treat and manage a wide range of health conditions.

In diagnostics, Abbott provides laboratory and point-of-care testing platforms and assays used to detect infectious diseases, chronic conditions and biomarkers; its Alinity family of instruments and rapid-test solutions are examples of this capability.